CEO: Joseph K. Belanoff

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Capital Market

Country: USA

Description: Corcept Therapeutics Inc is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders by modulating the effects of cortisol.


Key numbers

Market Capitalization:1878779640
Shares Outstanding: 114281000
Float: 102779531.598
Next Earning Date:2020-02-12
TTm EPS: 0.758
TTm Dividend Rate:
200 days moving average:12.21
50 days moving average: 14.3
One day percent Change: -1.82



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,